Product Information
MOTPOLY XR 200 MG CAPSULE is a brand product labeled by Aucta Pharmaceuticals, Inc., priced at $21.5109 per EA under NDC 73289006502. Its NADAC has been published 79 times since Feb 19, 2025.
FDA first approved this application on May 4, 2023.
The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Aucta Pharmaceuticals, Inc.NDC
73289006502
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
7/1/2026
Active Ingredients
LACOSAMIDEApproval Type
New Drug (NDA)
FDA Application
NDA216185FDA Approved
5/4/2023
On Market Since
5/5/2023
Pharmacological Classes
Price Statistics
The NADAC for MOTPOLY XR 200 MG CAPSULE has been published 79 times since Feb 19, 2025, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.5109 per EA |
|---|---|
| All-time high | $21.5109 (Aug 19, 2026) |
| All-time low | $20.3439 (Jun 18, 2025) |
| 52-week high | $21.5109 |
| 52-week low | $20.6239 |
| Median price | $20.6470 |
| Average price | $20.8493 |
| Largest weekly change | +3.0% (Jan 14, 2026) |
| Weeks tracked | 79 |
| Tracking since | Feb 19, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lacosamide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOTPOLY XR 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MOTPOLY XR 200 MG CAPSULE, manufactured by Aucta Pharmaceuticals, Inc., is $21.5109 per EA (NDC 73289006502), effective Aug 19, 2026.
How has the price of MOTPOLY XR 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MOTPOLY XR 200 MG CAPSULE has risen 5.5%. It has been tracked across 79 weekly CMS publications since Feb 19, 2025.
What are the highest and lowest recorded NADAC prices for MOTPOLY XR 200 MG CAPSULE?
Since Feb 19, 2025, the NADAC for MOTPOLY XR 200 MG CAPSULE has ranged from a low of $20.3439 (Jun 18, 2025) to a high of $21.5109 (Aug 19, 2026), with a median of $20.6470 per EA.
Are there cheaper alternatives to MOTPOLY XR 200 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of MOTPOLY XR 200 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MOTPOLY XR 200 MG CAPSULE?
MOTPOLY XR 200 MG CAPSULE (NDC 73289006502) is labeled by Aucta Pharmaceuticals, Inc., and CMS classifies it as a brand product.